Cargando…
Impact of Crystal Habit on the Dissolution Rate and In Vivo Pharmacokinetics of Sorafenib Tosylate
The dissolution rate is the rate-limiting step for Biopharmaceutics Classification System (BCS) class II drugs to enhance their in vivo pharmacokinetic behaviors. There are some factors affecting the dissolution rate, such as polymorphism, particle size, and crystal habit. In this study, to improve...
Autores principales: | Phan, Chi Uyen, Shen, Jie, Yu, Kaxi, Mao, Jianming, Tang, Guping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201088/ https://www.ncbi.nlm.nih.gov/pubmed/34200376 http://dx.doi.org/10.3390/molecules26113469 |
Ejemplares similares
-
Hydrogen Bonds, Topologies, Energy Frameworks and Solubilities of Five Sorafenib Salts
por: Phan, Chiuyen, et al.
Publicado: (2021) -
Co-Crystals of Resveratrol and Polydatin with L-Proline: Crystal Structures, Dissolution Properties, and In Vitro Cytotoxicities
por: Lou, Yijie, et al.
Publicado: (2021) -
Enhancing the Physiochemical Properties of Puerarin via L-Proline Co-Crystallization: Synthesis, Characterization, and Dissolution Studies of Two Phases of Pharmaceutical Co-Crystals
por: Inam, Muhammad, et al.
Publicado: (2021) -
Investigation of Solubility Behavior of Canagliflozin Hydrate Crystals Combining Crystallographic and Hirshfeld Surface Calculations
por: Zhu, Yefen, et al.
Publicado: (2021) -
Structural Polymorphism of Sorafenib Tosylate as a Key Factor in Its Solubility Differentiation
por: Wiergowska, Gabriela, et al.
Publicado: (2021)